# Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/human-mesenchymal-stem-cells-treatment-for-severe-covid-19-1-year-follow-up/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lei Shi,Xin Yuan,Weiqi Yao,Siyu Wang,Chao Zhang,Bo Zhang,Jin‐Wen Song,Lei Huang,Zhe Xu,Junliang Fu,Yuanyuan Li,Ruonan Xu,Tiantian Li,Jinghui Dong,Jianming Cai,Genshi Li,Yunbo Xie,Ming Shi,Yonggang Li,Yu Zhang,Wei‐Fen Xie,Fu‐Sheng Wang |
| Citations | 121 |
| DOI | 10.1016/j.ebiom.2021.103789 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1016/j.ebiom.2021.103789 |
| OpenAlex ID | https://openalex.org/W4226353396 |
| PMID | 34963099 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Tiantian Li](https://scholariq.org/researchers/tiantian-li/)

## Paper journal

- [EBioMedicine](https://scholariq.org/journals/ebiomedicine/)

## Paper primary topic

- [Mesenchymal stem cell research](https://scholariq.org/topics/mesenchymal-stem-cell-research/)

## Paper topics

- [Mesenchymal stem cell research](https://scholariq.org/topics/mesenchymal-stem-cell-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Dermatological and COVID-19 studies](https://scholariq.org/topics/dermatological-and-covid-19-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.